Skip to content
value.today

Levee Medical, Inc.

Formerly LuClaris, Inc.

Total raised
$10 M
2 rounds on record
Latest round
$7 M
Jul 2024
First round on record
Mar 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Levee Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$7 MNo. 2$2 to $10 million

Levee Medical, Inc.: Raise no. 2, Jul 2024

Investors in this round

70 investors had bought by the notice of Aug 15, 2024: 70 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Irving · Executive Officer, Director
  • Bruce Choi · Executive Officer, Director
  • Gary McCord · Director
  • Peter Mulrooney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Benjamin T. Jacob, Attorney-in-fact. Newest notice filed Aug 15, 2024. Read the notice at the SEC.

equitySEC
Mar 2022$3 MNo. 1$2 to $10 million

Levee Medical, Inc.: Raise no. 1, Mar 2022

Investors in this round

54 investors had bought by the notice of Jul 13, 2022: 54 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Irving · Executive Officer, Director
  • Bruce Choi · Executive Officer, Director
  • Gary McCord · Director
  • Peter Mulrooney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Benjamin T. Jacob, Attorney-in-fact. Newest notice filed Jul 13, 2022 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Levee Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Levee Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Levee Medical, Inc.
NameRoleNamed in
Adam IrvingExecutive officerAug 2024
Bruce ChoiExecutive officerAug 2024
Adam IrvingDirectorAug 2024
Bruce ChoiDirectorAug 2024
Gary McCordDirectorAug 2024
Peter MulrooneyDirectorAug 2024